Other competencies
- Specialist in hematology (FMH)
- Specialist in internal medicine and hematology and oncology (D)
- Additional qualification in hemostaseology (D)
- Additional qualification in immunology (D)
- Additional qualification in palliative medicine (D)
- Additional qualification in emergency medicine (D)
Career History
- since 2022 Senior Attending Physician and Program Director Stem Cell Transplantation and Cellular Therapies, Department of Medical Oncology and Hematology, University Hospital Zurich
- 2019-2022 Attending Physician, Internal Medicine II, University Hospital Tübingen
- 2012-2015 Postdoctoral Fellow, Division of Blood and Marrow Transplantation, Stanford University, USA
- 2010-2019 Doctor in postgraduate training, Internal Medicine II, University Hospital Tübingen
- 2004-2010 Study of human medicine, University of Ulm
Most important memberships
- Member of the Board of Directors of the USZ Transplant Center
- German Society for Hematology and Medical Oncology (DGHO)
- German Association for Hematopoietic Stem Cell Transplantation and Cellular Therapy (DAG-HSZT)
Key Research Areas
- Cellular Therapies
- Allogeneic stem cell transplantation
- Graft-versus-Host Disease
- Invariant natural killer T cells
- Chimeric Antigen Receptors
- Immune dysregulation
Publication list
https://pubmed.ncbi.nlm.nih.gov/?term=Schneidawind+D&sort=date
More
- 2016 DAG-KBT Research Award of the German Working Group for Bone Marrow and Blood Stem Cell Transplantation
- 2015 New Investigator Award of the American Society for Blood and Marrow Transplantation
- 2014 Best Abstract Award for Basic Science Research of the American Society for Blood and Marrow Transplantation